We are a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with liver and other chronic diseases with high unmet medical need. We are evaluating seladelpar in primary biliary cholangitis (PBC). We also have a product program in earlier development that features a unique mechanism of action with potential in chronic diseases.
Company Profile
Industry Classifications
Sector:
Healthcare
Industry:
Biotechnology
NAICS:
Pharmaceutical Preparation Manufacturing (325412)
SIC:
Pharmaceutical Preparations (2834)
Contact Information
Media
Inizio Evoke
Theresa Dolge
T: (609) 915-2156
Theresa.Dolge@inizioevoke.com
Company Contact
CymaBay Therapeutics
7601 Dumbarton Circle
Fremont, CA 94555
T: (510) 293-8800
F: (510) 293-9090
info@cymabay.com